Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationFRA:5IR +1.14%92 EV-to-OCF is 14.78 as of Aug. 28, 2026, which is 48% above its 10-year median of 9.96. GuruFocus rates FRA:5IR with a GF Score™ of 92/100 and a GF Value™ of €1.63. The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, China Isotope & Radiation ranks worse than 64.79% on this metric.
The historical rank and industry rank for China Isotope & Radiation's EV-to-OCF or its related term are showing as below:
FRA:5IR'
s EV-to-OCF Range Over the Past 10 Years
Min: 3.55 Med: 9.96 Max: 67.98
Current: 14.61
During the past 11 years, the highest EV-to-OCF of China Isotope & Radiation was 67.98. The lowest was 3.55. And the median was 9.96.
FRA:5IR's EV-to-OCF is ranked worse than 64.79% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.88
vs FRA:5IR: 14.61
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Isotope & Radiation (FRA:5IR) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Isotope & Radiation's PE Ratio (TTM) for today is calculated as:
China Isotope & Radiation's share price for today is €1.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.123.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Isotope & Radiation EV-to-OCF Related Terms
China Isotope & Radiation EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, China Isotope & Radiation's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's EV-to-OCF falls into.
China Isotope & Radiation's current Enterprise Value is €966.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €65.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (FRA:5IR) has a EV-to-OCF of 14.78 as of Aug. 28, 2026. This is 48% above median its historical median of 9.96. Over the past decade, China Isotope & Radiation's EV-to-OCF has ranged from 3.55 to 67.98. According to the industry distribution chart, China Isotope & Radiation ranks #552 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 64.8%.
Is China Isotope & Radiation's EV-to-OCF too high?
China Isotope & Radiation's current EV-to-OCF of 14.78 is 48% above median its 10-year median of 9.96. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 67.98. The Medical Devices & Instruments industry median EV-to-OCF is 7.88. China Isotope & Radiation's value of 14.78 is 87.6% above this industry median. Based on the distribution chart, China Isotope & Radiation ranks #552 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, China Isotope & Radiation has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #552 out of 852 companies for EV-to-OCF. This places China Isotope & Radiation in the lower half of its industry. The industry median EV-to-OCF is 7.88. China Isotope & Radiation's value of 14.78 is 87.6% above this benchmark. Historically, China Isotope & Radiation's own EV-to-OCF has ranged from 3.55 to 67.98 over the past decade. While the company's 10-year median is 9.96 vs. the industry median of 7.88, China Isotope & Radiation has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.88, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current EV-to-OCF of 14.78 is 87.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current EV-to-OCF is 14.78, which is 48% above median its own 10-year median of 9.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
China Isotope & Radiation (FRA:5IR) has a current EV-to-OCF of 14.78. The stock's GF Value™ is €1.63, compared to a current price of €1.77 — trading 8.6% above its estimated fair value. The current EV-to-OCF is 14.78, which is 48% above median its 10-year median of 9.96 and 87.6% above the Medical Devices & Instruments industry median of 7.88. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For China Isotope & Radiation (FRA:5IR), the current EV-to-OCF is 14.78 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (FRA:5IR) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of €1.77 is trading 8.6% above its estimated GF Value™ of €1.63.
Key valuation signals for FRA:5IR:
EV-to-OCF: 14.78 (48% above median its 10-year median of 9.96)
GF Value™: €1.63 vs. price of €1.77 (8.6% above fair value)
Industry Position: 87.6% above the Medical Devices & Instruments median (#552 of 852)
No single metric tells the full story. See the FRA:5IR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for FRA:5IR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5IR has been successfully added to your 
